Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Medtronic plc Explores Global Options to Escape Trump Tariffs

February 28, 2025
Medtronic, a leading medical technology company, is actively looking for ways to navigate the current economic landscape and avoid the impact of Trump tariffs. The company's management team is exploring various global options to mitigate the effects of the trade war, which has been shaking the stock market recently.

Medtronic plc has long been known for its innovative medical devices and breakthrough solutions. The company's latest creation, the Adaptive deep brain stimulation system for people with Parkinson's disease, has recently received the approval of the U.S. Food and Drug Administration (FDA). This revolutionary system opens up new possibilities for patients suffering from Parkinson's, offering them a more personalized and effective treatment approach.

Despite the positive news regarding FDA approval, Medtronic's stock has been experiencing some volatility due to the ongoing trade dispute between the United States and China. The company has been assessing its global operations and considering potential shifts in its supply chain to minimize the impact of tariffs imposed on imported medical devices.

Medtronic's expansion plans also remain a key factor in its efforts to drive growth and sustainability. With the market rebound anticipated in the coming months, the company's continued momentum and focus on product innovation position it well for future success.

For investors interested in Medtronic's stock, seeking professional guidance from industry experts such as Stocks Prognosis may provide valuable insights and forecasts on the future movement of the company's shares. As Medtronic plc explores global options to escape Trump tariffs and adapts to the evolving market conditions, investors are advised to consider a comprehensive analysis of the stock's prospects.
If you want to leave a comment, then you need Login or Register





Other data for MDT

Related data

MDTJuly 22, 2025QuantWave Successfully Predicts 8.91% Profit on MEDTRONIC PLC Stock  ~2 min.

QuantWave, the leading automated forecasting platform, has once again demonstrated its accuracy with the successful prediction of a price target for MEDTRONIC PLC....


MDTJuly 22, 2025Medical Device Giant MEDTRONIC PLC Hits Price Target Forecast, Generating 8.01% Profit  ~1 min.

On May 2, 2025, QuantWave, the automated forecasting platform, issued a long signal for the stock of MEDTRONIC PLC when it was trading at $84.85....


MDTJuly 11, 2025QuantWave Forecast Hits the Mark: MEDTRONIC PLC Achieves 4.98% Profit Target  ~2 min.

On May 20, 2025, QuantWave, the automated forecasting platform, issued a long signal for MEDTRONIC PLC with a price of $85.66. Fast forward to July 11, 2025, and the stock had surged to $89....


MDTJuly 10, 2025QuantWave Forecast Achieves 5.91% Profit Target for MEDTRONIC PLC  ~1 min.

On May 21, 2025, QuantWave, the automated forecasting platform, issued a long signal for MEDTRONIC PLC (MDT) when the stock was trading at $84.41....


MDTJuly 10, 2025Profit Alert: MEDTRONIC PLC Stock Hits Price Target with 6.79% Gain  ~1 min.

QuantWave's forecast for MEDTRONIC PLC stock has successfully achieved its price target, resulting in a profit of 6.79%. The forecast signal date was 2025-05-21, with a price of 83....


MDTJuly 9, 2025QuantWave Successfully Hits Price Target Forecast for MEDTRONIC PLC with Profit of 4.89%  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has achieved yet another milestone with the successful prediction and realization of a price target forecast for MEDTRONIC PLC....


MDTJuly 9, 2025QuantWave Forecasts Success: MEDTRONIC PLC Price Target Hit with 6.65% Profit  ~1 min.

On May 5, 2025, QuantWave issued a long signal for MEDTRONIC PLC when the stock was priced at 83.45 $. The forecast proved to be accurate as the target of 89....


MDTJuly 9, 2025QuantWave Successfully Achieves Forecast Price Target for MEDTRONIC PLC with 7.54% Profit  ~2 min.

On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for the stock of MEDTRONIC PLC at a price of 82.76 $....


MDTJuly 9, 2025QuantWave Successfully Achieves 5.76% Profit Target for MEDTRONIC PLC  ~1 min.

In an impressive display of accuracy, QuantWave, the automated forecasting platform, has successfully reached its price target forecast for MEDTRONIC PLC....


MDTJuly 6, 2025Medtronic PLC Enters Strategic Partnership with Philips to Expand Patient Monitoring Technology  ~1 min.

Medtronic PLC has recently announced a strategic partnership with Philips to enhance access to patient monitoring technology....


MDTFebruary 27, 2025Medtronic plc MDT: Revolutionary Adaptive Brain Stimulation System for Parkinson's Disease Receives FDA Approval  ~1 min.

Medtronic, a leader in medical technology, has recently earned the U.S. FDA's approval for its groundbreaking adaptive deep brain stimulation system for individuals with Parkinson's disease....


ABBVDecember 14, 2024AbbVie Inc. Reports Positive Phase 3 Data for Tavapadon  ~1 min.

AbbVie Inc. (NYSE:ABBV) recently released the Phase 3 data for its investigational drug, tavapadon, for the treatment of Parkinson's disease....


MDTFebruary 26, 2025MDT Medtronic PLC's Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and Neuromodulation Segments  ~2 min.

Medtronic PLC, a global leader in medical technology, recently announced its Q3 2025 earnings call highlights, showcasing strong growth in its cardiac and neuromodulation segments....


GSKJanuary 10, 2025GSK PLC's ADC Receives US FDA Breakthrough Therapy Designation  ~1 min.

GSK PLC's antibody-drug conjugate (ADC) has recently been granted the breakthrough therapy designation by the US Food and Drug Administration (FDA)....


MDTJanuary 15, 2025Medtronic PLC Receives CE Mark Approval for Groundbreaking BrainSense Adaptive Deep Brain Stimulation  ~2 min.

Medical technology company Medtronic PLC (MDT) has announced that it has received CE Mark approval for its revolutionary BrainSense Adaptive deep brain stimulation (DBS) system....